References
- Monitoramento dos casos de microcefalias no Brasil. 2015; Brasil Ministério da Saúde. Available from: http://portalarquivos2.saude.gov.br/images/pdf/2015/dezembro/30/COES-Microcefalias—-Informe-Epidemiol–gico—SE-51—29dez2015—15h.pdf
- SA R, DJ J, MA H, et al. Zika virus and birth defects–reviewing the evidence for causality. N Engl J Med. 2016;374(20):1981–1987.
- Brasil P, Pereira JP Jr., Moreira ME, et al. Zika virus infection in pregnant women in Rio de Janeiro. N Engl J Med. 2016;375(24):2321–2334.
- Jaenisch T, Rosenberger KD, Brito C, et al. Risk of microcephaly after Zika virus infection in Brazil, 2015 to 2016. Bull World Health Organ. 2017;95(3):191–198.
- GS C, AC B, SI S. Zika virus Outbreak, Bahia, Brazil. Emerg Infect Dis. 2015;21(10):1885–1886.
- Proenca-Modena JL, Milanez GP, Costa ML, et al. Zika virus: lessons learned in Brazil. Microbes Infect. 2018;20(11–12):661–669.
- Emergency Committee on Zika virus and observed increase in neurological disorders and neonatal malformations. 2016; World Health Organization. Available from:https://www.who.int/en/news-room/detail/01-02-2016-who-statement-on-the-first-meeting-of-the-international-health-regulations-(2005)-(ihr-2005)-emergency-committee-on-zika-virus-and-observed-increase-in-neurological-disorders-and-neonatal-malformations
- Consensus on causal link between Zika and neurological disorders. 2016; World Health Organization. Available from: http://www.euro.who.int/en/health-topics/emergencies/zika-virus/news/news/2016/04/consensus-on-causal-link-between-zika-and-neurological-disorders
- Chakhtoura N, Hazra R, Spong CY. Zika virus: a public health perspective. Curr Opin Obstet Gynecol. 2018;30(2):116–122.
- Hayes EB. Zika virus outside Africa. Emerg Infect Dis. 2009;15(9):1347–1350.
- Duffy MR, Chen TH, Hancock WT, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med. 2009;360(24):2536–2543.
- Song BH, Yun SI, Woolley M, et al. Zika virus: history, epidemiology, transmission, and clinical presentation. J Neuroimmunol. 2017;308:50–64.
- Heerema-McKenney A. Defense and infection of the human placenta. APMIS. 2018;126(7):570–588.
- Tabata T, Petitt M, Puerta-Guardo H, et al. Zika virus targets different primary human placental cells, suggesting two routes for vertical transmission. Cell Host Microbe. 2016;20(2):155–166.
- Quicke KM, Bowen JR, Johnson EL, et al. Zika virus infects human placental macrophages. Cell Host Microbe. 2016;20(1):83–90.
- Jurado KA, Simoni MK, Tang Z, et al. Zika virus productively infects primary human placenta-specific macrophages. JCI Insight. 2016;1:13.
- Simoni MK, Jurado KA, Abrahams VM, et al. Zika virus infection of hofbauer cells. Am J Reprod Immunol. 2017;77:2.
- Zorrilla CD, Rivera-Vinas JI, De La Vega-Pujols A, et al. The Zika virus infection in pregnancy: review and implications for research and care of women and infants in affected areas. P R Health Sci J. 2018;37(Special Issue):S66–S72.
- Chibueze EC, Tirado V, Lopes KD, et al. Zika virus infection in pregnancy: a systematic review of disease course and complications. Reprod Health. 2017;14(1):28.
- Melo AS, Aguiar RS, Amorim MM, et al. Congenital Zika virus infection: beyond neonatal microcephaly. JAMA Neurol. 2016;73(12):1407–1416.
- Musso D, Cao-Lormeau VM, Gubler DJ. Zika virus: following the path of dengue and chikungunya? Lancet. 2015;386(9990):243–244.
- Musso D, Baud D. Zika virus: time to move from case reports to case control. Lancet Infect Dis. 2016;16(6):620–621.
- Diamond MS, Ledgerwood JE, Pierson TC. Zika Virus vaccine development: progress in the face of new challenges. Annu Rev Med. 2018;70:121–135.
- Shan C, Xie X, Shi PY. Zika virus vaccine: progress and challenges. Cell Host Microbe. 2018;24(1):12–17.
- Abbink P, Stephenson KE, Barouch DH. Zika virus vaccines. Nat Rev Microbiol. 2018;16(10):594–600.
- Richner JM, Diamond MS. Zika virus vaccines: immune response, current status, and future challenges. Curr Opin Immunol. 2018;53:130–136.
- Arora N, Sadovsky Y, Dermody TS, et al. Microbial vertical transmission during human pregnancy. Cell Host Microbe. 2017;21(5):561–567.
- Faye-Petersen OM, Heller DS, Joshi VV. Handbook of placental pathology. 2nd ed. Abingdon, Oxon, UK: Taylor & Francis; 2006.
- Malassine A, Frendo JL, Evain-Brion D. A comparison of placental development and endocrine functions between the human and mouse model. Hum Reprod Update. 2003;9(6):531–539.
- Watson ED, Cross JC. Development of structures and transport functions in the mouse placenta. Physiology (Bethesda). 2005;20:180–193.
- Lazear HM, Govero J, Smith AM, et al. A mouse model of Zika virus pathogenesis. Cell Host Microbe. 2016;19(5):720–730.
- Grant A, Ponia SS, Tripathi S, et al. Zika virus targets human STAT2 to inhibit type i interferon signaling. Cell Host Microbe. 2016;19(6):882–890.
- Kumar A, Hou S, Airo AM, et al. Zika virus inhibits type-I interferon production and downstream signaling. EMBO Rep. 2016;17(12):1766–1775.
- Miner JJ, Cao B, Govero J, et al. Zika virus infection during pregnancy in mice causes placental damage and fetal demise. Cell. 2016;165(5):1081–1091.
- Yockey LJ, Jurado KA, Arora N, et al. Type I interferons instigate fetal demise after Zika virus infection. Sci Immunol. 2018;3:19.
- Casazza RL, Lazear HM. Antiviral immunity backfires: pathogenic effects of type I interferon signaling in fetal development. Sci Immunol. 2018;3:19.
- Bayer A, Lennemann NJ, Ouyang Y, et al. Type III interferons produced by human placental trophoblasts confer protection against Zika virus infection. Cell Host Microbe. 2016;19(5):705–712.
- Chen J, Liang Y, Yi P, et al. Outcomes of congenital Zika disease depend on timing of infection and maternal-fetal interferon action. Cell Rep. 2017;21(6):1588–1599.
- Hastings AK, Yockey LJ, Jagger BW, et al. TAM Receptors Are Not Required for Zika Virus Infection in Mice. Cell Rep. 2017;19(3):558–568.
- Caine EA, Scheaffer SM, Arora N, et al. Interferon lambda protects the female reproductive tract against Zika virus infection. Nat Commun. 2019;10(1):280.
- Yockey LJ, Varela L, Rakib T, et al. Vaginal exposure to Zika virus during pregnancy leads to fetal brain infection. Cell. 2016;166(5):1247–56 e4.
- Uraki R, Jurado KA, Hwang J, et al. Fetal growth restriction caused by sexual transmission of Zika virus in mice. J Infect Dis. 2017;215(11):1720–1724.
- Vermillion MS, Lei J, Shabi Y, et al. Intrauterine Zika virus infection of pregnant immunocompetent mice models transplacental transmission and adverse perinatal outcomes. Nat Commun. 2017;8:14575.
- Szaba FM, Tighe M, Kummer LW, et al. Zika virus infection in immunocompetent pregnant mice causes fetal damage and placental pathology in the absence of fetal infection. PLoS Pathog. 2018;14(4):e1006994.
- Gorman MJ, Caine EA, Zaitsev K, et al. An Immunocompetent mouse model of Zika virus infection. Cell Host Microbe. 2018;23(5):672–85 e6.
- Luo H, Winkelmann ER, Fernandez-Salas I, et al. Zika, dengue and yellow fever viruses induce differential anti-viral immune responses in human monocytic and first trimester trophoblast cells. Antiviral Res. 2018;151:55–62.
- Novak CM, Lee JY, Ozen M, et al. Increased placental T cell trafficking results in adverse neurobehavioral outcomes in offspring exposed to sub-chronic maternal inflammation. Brain Behav Immun. 2019;75:129–136.
- Cao B, Macones C, Mysorekar IU. ATG16L1 governs placental infection risk and preterm birth in mice and women. JCI Insight. 2016;1(21):e86654.
- Delorme-Axford E, Donker RB, Mouillet JF, et al. Human placental trophoblasts confer viral resistance to recipient cells. Proc Natl Acad Sci U S A. 2013;110(29):12048–12053.
- Ke PY. The multifaceted roles of autophagy in flavivirus-host interactions. Int J Mol Sci. 2018;19:12.
- Cao B, Parnell LA, Diamond MS, et al. Inhibition of autophagy limits vertical transmission of Zika virus in pregnant mice. J Exp Med. 2017;214(8):2303–2313.
- Yuan S, Zhang ZW, Li ZL. Trehalose may decrease the transmission of Zika virus to the fetus by activating degradative autophagy. Front Cell Infect Microbiol. 2017;7:402.
- Cao B, Sheth MN, Mysorekar IU. To Zika and destroy: an antimalarial drug protects fetuses from Zika infection. Future Microbiol. 2018;13:137–139.
- Chiramel AI, Best SM. Role of autophagy in Zika virus infection and pathogenesis. Virus Res. 2018;254:34–40.
- Abernathy E, Mateo R, Majzoub K, et al. Differential and convergent utilization of autophagy components by positive-strand RNA viruses. PLoS Biol. 2019;17(1):e2006926.
- Wu KY, Zuo GL, Li XF, et al. Vertical transmission of Zika virus targeting the radial glial cells affects cortex development of offspring mice. Cell Res. 2016;26(6):645–654.
- Cugola FR, Fernandes IR, Russo FB, et al. The Brazilian Zika virus strain causes birth defects in experimental models. Nature. 2016;534(7606):267–271.
- Setia H, Muotri AR. Brain organoids as a model system for human neurodevelopment and disease. Semin Cell Dev Biol. 2019.
- Qian X, Nguyen HN, Jacob F, et al. Using brain organoids to understand Zika virus-induced microcephaly. Development. 2017;144(6):952–957.
- Garcez PP, Loiola EC, Madeiro Da Costa R, et al. Zika virus impairs growth in human neurospheres and brain organoids. Science. 2016;352(6287):816–818.
- Dang J, Tiwari SK, Lichinchi G, et al. Zika virus depletes neural progenitors in human cerebral organoids through activation of the innate immune receptor TLR3. Cell Stem Cell. 2016;19(2):258–265.
- Kuno G, Chang GJ. Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses. Arch Virol. 2007;152(4):687–696.
- Bollati M, Alvarez K, Assenberg R, et al. Structure and functionality in flavivirus NS-proteins: perspectives for drug design. Antiviral Res. 2010;87(2):125–148.
- Xu M, Lee EM, Wen Z, et al. Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen. Nat Med. 2016;22(10):1101–1107.
- Barrows NJ, Campos RK, Powell ST, et al. A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection. Cell Host Microbe. 2016;20(2):259–270.
- Rausch K, Hackett BA, Weinbren NL, et al. Screening bioactives reveals nanchangmycin as a broad spectrum antiviral active against Zika virus. Cell Rep. 2017;18(3):804–815.
- Bullard-Feibelman KM, Govero J, Zhu Z, et al. The FDA-approved drug sofosbuvir inhibits Zika virus infection. Antiviral Res. 2017;137:134–140.
- Chan JF, Chik KK, Yuan S, et al. Novel antiviral activity and mechanism of bromocriptine as a Zika virus NS2B-NS3 protease inhibitor. Antiviral Res. 2017;141:29–37.
- Liang Q, Luo Z, Zeng J, et al. Zika virus NS4A and NS4B proteins deregulate Akt-mTOR signaling in human fetal neural stem cells to inhibit neurogenesis and induce autophagy. Cell Stem Cell. 2016;19(5):663–671.
- Kumar A, Liang B, Aarthy M, et al. Hydroxychloroquine Inhibits Zika Virus NS2B-NS3 Protease. ACS Omega. 2018;3(12):18132–18141.
- Shiryaev SA, Mesci P, Pinto A, et al. Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis. Sci Rep. 2017;7(1):15771.
- Sperber K, Hom C, Chao CP, et al. Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases. Pediatr Rheumatol Online J. 2009;7:9.
- Costedoat-Chalumeau N, Amoura Z, Duhaut P, et al. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum. 2003;48(11):3207–3211.
- Motta M, Tincani A, Faden D, et al. Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation. J Perinatol. 2005;25(2):86–89.
- Bermas BL. Too little of a good thing: hydroxychloroquine in pregnancy. J Rheumatol. 2019;46(1):1–2.
- Krauer F, Riesen M, Reveiz L, et al. Zika virus infection as a cause of congenital brain abnormalities and guillain-barre syndrome: systematic review. PLoS Med. 2017;14(1):e1002203.
- Ritter JM, Martines RB, Zaki SR. Zika virus: pathology from the pandemic. Arch Pathol Lab Med. 2017;141(1):49–59.
- Morrison TE, Diamond MS. Animal models of Zika virus infection, pathogenesis, and immunity. J Virol. 2017;91:8.
- Fernandez E, Diamond MS. Vaccination strategies against Zika virus. Curr Opin Virol. 2017;23:59–67.
- Alvarado MG, Schwartz DA. Zika virus infection in pregnancy, microcephaly, and maternal and fetal health: what we think, what we know, and what we think we know. Arch Pathol Lab Med. 2017;141(1):26–32.
- Robinson N, Mayorquin Galvan EE, Zavala Trujillo IG, et al. Congenital Zika syndrome: pitfalls in the placental barrier. Rev Med Virol. 2018;28(5):e1985.
- Cao B, Diamond MS, Mysorekar IU. Maternal-fetal transmission of Zika virus: routes and signals for infection. J Interferon Cytokine Res. 2017;37(7):287–294.
- McNeil CJ, Shetty AK. Zika virus: a serious global health threat. J Trop Pediatr. 2017;63(3):242–248.
- Marrs C, Olson G, Saade G, et al. Zika virus and pregnancy: a review of the literature and clinical considerations. Am J Perinatol. 2016;33(7):625–639.
- Mysorekar IU, Diamond MS. Modeling Zika virus infection in pregnancy. N Engl J Med. 2016;375(5):481–484.
- Noronha L, Zanluca C, Azevedo ML, et al. Zika virus damages the human placental barrier and presents marked fetal neurotropism. Mem Inst Oswaldo Cruz. 2016;111(5):287–293.
- Martines RB, Bhatnagar J, de Oliveira Ramos AM, et al. Pathology of congenital Zika syndrome in Brazil: a case series. Lancet. 2016;388(10047):898–904.
- Martines RB, Bhatnagar J, Keating MK, et al. Notes from the field: evidence of Zika Virus infection in brain and placental tissues from two congenitally infected newborns and two fetal Losses–Brazil, 2015. MMWR Morb Mortal Wkly Rep. 2016;65(6):159–160.
- Eppes C, Rac M, Dunn J, et al. Testing for Zika virus infection in pregnancy: key concepts to deal with an emerging epidemic. Am J Obstet Gynecol. 2017;216(3):209–225.
- Health BMo. PROTOCOLO DE VIGILÂNCIA E RESPOSTA À OCORRÊNCIA DE MICROCEFALIA E/OU ALTERAÇÕES DO SISTEMA NERVOSO CENTRAL (SNC) Available from:http://combateaedes.saude.gov.br/images/sala-de-situacao/Microcefalia-Protocolo-de-vigilancia-e-resposta-10mar2016-18h.pdf2016
- van der Eijk AA, van Genderen PJ, Verdijk RM, et al. Miscarriage associated with Zika virus infection. N Engl J Med. 2016;375(10):1002–1004.
- Rosenberg AZ, Yu W, Hill DA, et al. Placental pathology of Zika virus: viral infection of the placenta induces villous stromal macrophage (hofbauer cell) proliferation and hyperplasia. Arch Pathol Lab Med. 2017;141(1):43–48.
- Chen L, Hafeez F, Curry CL, et al. Cutaneous Eruption in a U.S. Woman with locally acquired Zika virus infection. N Engl J Med. 2017;376(4):400–401.
- Schaub B, Vouga M, Najioullah F, et al. Analysis of blood from Zika virus-infected fetuses: a prospective case series. Lancet Infect Dis. 2017;17(5):520–527.
- Acosta-Reyes J, Navarro E, Herrera MJ, et al. Severe neurologic disorders in 2 fetuses with Zika virus infection, Colombia. Emerg Infect Dis. 2017;23(6):982–984.
- Franca GV, Schuler-Faccini L, Oliveira WK, et al. Congenital Zika virus syndrome in Brazil: a case series of the first 1501 livebirths with complete investigation. Lancet. 2016;388(10047):891–897.
- Figueiredo LT. The recent arbovirus disease epidemic in Brazil. Rev Soc Bras Med Trop. 2015;48(3):233–234.
- Fact sheet: abortion in Latin America and the Caribbean 2015; Guttmacher Institute. Available from: https://www.guttmacher.org/pubs/IB_AWW-Latin-America.pdf
- Charlier C, Beaudoin MC, Couderc T, et al. Arboviruses and pregnancy: maternal, fetal, and neonatal effects. Lancet Child Adolesc Health. 2017;1(2):134–146.
- Lecuit M, Nguyen L. Lessons learnt from the emergence of Zika virus. Nat Microbiol. 2018;3(9):966–968.